U.S. STOCKS ON THE MOVE-Medalist Diversified REIT, Xeris Biopharma, Eros STX

US Xpress Enterprises

31/12/2021 12:14

* Eikon search string for individual stock moves:  STXBZ 
    * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
    * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh

U.S. stock index futures slipped on Friday, even as Wall Street's main indexes
looked to finish the year with handsome gains for the third time in a row,
supported by massive stimulus, vaccine rollouts, and strong retail
participation.  .N 
    At 6:55 ET, Dow e-minis  1YMc1  were down 0.21% at 36,216. S&P 500 e-minis
 ESc1  were down 0.21% at 4,762, while Nasdaq 100 e-minis  NQc1  were down 0.26%
at 16,387.5.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Altimar Acquisition Corp II  FATH.N , up 49.1%
 ** Compass Inc  COMP.N , up 6.6%
 ** Eros STX Global Corp  ESGC.N , up 5.7%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** U.S. Xpress Enterprises Inc  USX.N , down 25.4%
 ** CNX Resources Corp  CNX.N , down 9%
 ** Douglas Elliman Inc  DOUG.N , down 7.7%
 
 The top two Nasdaq percentage gainers premarket  .PRPG.O :
 ** Medalist Diversified Reit Inc  MDRR.O , up 30.4%
 ** Aspen Group Inc  ASPU.O , up 21.8%
 
 The top Nasdaq percentage loser premarket  .PRPL.O :
 ** Stryve Foods Inc  SNAX.O , down 11.5%
   
 
    ** Medalist Diversified REIT Inc  MDRR.O : up 30.4% premarket
 BUZZ-Medalist Diversified REIT gains on share buyback plan  urn:newsml:reuters.com:*:nL4N2TG1GT
    
    ** Xeris Biopharma Holdings Inc  XERS.O : up 19.3% premarket
 BUZZ-Xeris rises after FDA approves rare disorder treatment  urn:newsml:reuters.com:*:nL4N2TG1HT


 (Compiled by Ananya Mariam Rajesh in Bengaluru)
 ((AnanyaMariam.Rajesh@thomsonreuters.com))